GE Healthcare To Pay Up For Export Violations
GE Healthcare Bioscience BioProcess Corp. has agreed to pay $126,000 to resolve allegations that it exported and re-exported bioreactor kits to China, Mexico and elsewhere without obtaining the proper licenses from...To view the full article, register now.
Already a subscriber? Click here to view full article